NNovo Nordisk Read More Novo Nordisk backs India’s sickle cell elimination by 20472026-10-16 Danish pharma giant Novo Nordisk has pledged support for India’s National Sickle Cell Anaemia Elimination Mission, targeting 2047.…
NNovo Nordisk Read More Novo Nordisk Balances Canadian Price Pressure With Sickle Cell Advance and Oral Pill Triumph2026-05-13 Novo Nordisk rebounds 31% on obesity data, but Canada generic semaglutide threatens pricing. Wegovy oral pill sales surge…
NNovo Nordisk Read More Novo Nordisk’s Sickle Cell Drug Delivers as Buyback Program Advances2026-04-21 Novo Nordisk’s oral sickle cell drug etavopivat met Phase 3 goals, cutting painful crises by 27%. The success…
NNovo Nordisk Read More Novo Nordisk’s Sickle Cell Success Charts a New Path Beyond Blockbuster Drugs2026-04-21 Novo Nordisk’s etavopivat reduces sickle cell crises by 27% in Phase 3 trial, marking a key diversification move…
NNovo Nordisk Read More Novo Nordisk’s Sickle Cell Success Charts a New Path Beyond Blockbuster Drugs2026-04-21 Novo Nordisk’s etavopivat reduces sickle cell crises by 27% in Phase 3 trial, marking a key diversification move…